Clinical Trials Browser

Uveal Melanoma, Glioma, Adenoma, Islet Cell, Laryngeal Diseases, Medulloblastoma, Melanoma, Mesothelioma, Neuroblastoma, Pituitary Diseases, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Osteosarcoma

Clinical Trials

A Study of Azenosertib (ZN-c3) in Participants With Solid Tumors

A Study to Test How Well Different Doses of BI 3706674 Are Tolerated by People With Advanced Cancer in the Stomach and Oesophagus

Phase Ia/Ib Study of RS-0139 in Patients With a Recurrent, Locally Advanced or Metastatic Solid Tumors

A Phase 1 Study of SAIL66 in Patients With CLDN6-positive Locally Advanced or Metastatic Solid Tumors

5fr SBRT

Short Neoadjuvant Hemithoracic IMRT for MPM

A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations

From Presentation to Diagnosis: Patterns of Pleural Effusion

GUIDE

Evaluation of 3D Surface Scanning for Virtual-CT Based Radiation Therapy Treatment Planning

Study to Explore the Safety, Tolerability, and Pharmacokinetics of AMG 305 in Subjects With Advanced Solid Tumors

SKYSCRAPER-11

A Study to Test the Safety of the Investigational Drug Larotrectinib in Adults That May Treat Cancer

MesoPDT

Assessment of Safety, Tolerability and PK Profile of MSP008-22 in Patients With Advanced Solid Tumours

A Study in People With Advanced Cancer to Test Whether the Amount of BI 907828 in the Blood is Influenced by Taking an OATP Inhibitor or a CYP3 Inhibitor

Screening Study for Participants With Malignant Tumors

Attention Bias Modification for the Improvement of Anxiety in Adolescent and Young Adult Cancer Survivors

Basket Study of Leronlimab (PRO 140) in Patients With CCR5+ Locally Advanced or Metastatic Solid Tumors

CheckMate 6DW

DREAM3R

Self-Administered Relaxing Acupressure to Reduce Fatigue in Adolescent and Young Adult Cancer Survivors

PEMBIB

Anti-ALPP CAR-T Cells Immunotherapy for Advanced Solid Tumors

ALPP CAR-T Cells for ALPP-Positive Advanced Solid Tumors

Feasibility of the LUM Imaging System for Peritoneal Surface Malignancies

Topical Cannabidiol for the Treatment of Chemotherapy-Induced Peripheral Neuropathy

A First-in-Human Study of JAB-8263 in Adult Patients With Advanced Solid Tumors

A Phase 1b/2 Study of ADG116, ADG116 Combined With Anti-PD-1 Antibody or Anti-CD137 Antibody in Solid Tumors Patients

A Phase I /IIa Study of RC88-ADC in Subjects With Advanced Malignant Solid Tumors

First-in-Human, Phase I, Open-label, Multicenter, Dose Escalation Clinical Study

A Study of RC108-ADC in Subjects With Advanced Malignant Solid Tumors

JAB-BX102 Monotherapy and Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors

The Primary Objective of This Study to Evaluate the Safety and Tolerability of IBI334 and Determine the Maximum Tolerated Dose (MTD) and the Recommended Phase 2 Dose (RP2D)and Anti Tumor Activity of IBI334.

Study of ZGGS15 in Patients With Advanced Solid Tumors

......SMARTEST Trial......

EVICTION-2

BIMES

RAPIRI

A Study of NB003 in Patients With Advanced Malignancies

A Study to Assess the Safety and Tolerability of RC88 for Patients With Advanced Solid Tumours

Transarterial Chemoperfusion: Cisplatin, Methotrexate, Gemcitabine for Unresectable Pleural Mesothelioma

Recombinant Interleukin-15 in Combination With Checkpoint Inhibitors Nivolumab and Ipilimumab in People With Refractory Cancers

A Phase 1 Study of RO7623066 Alone and in Combination in Patients With Advanced Solid Tumors

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASC61in Subjects With Advanced Solid Tumors

A Study of TAK-981 Given With Pembrolizumab in Participants With Select Advanced or Metastatic Solid Tumors

Assessment of Safety and Preliminary Efficacy With BAT6026 in Solid Tumor Patients in China

Assessment of Safety ,Tolerance and Pharmacokinetics Clinical Efficacy With BAT1308 in Advanced Solid Tumors

A Study of KL340399 in Patients With Advanced Solid Tumors

A Study of Intratumoral KL340399 in Patients With Advanced Solid Tumors